1AD
Click for more information
0.00% 2.5¢ adalta limited

Ann: SYNThesis BioVentures MoU for cellular immunotherapies, page-51

  1. asx11
    3,319 Posts.
    lightbulb Created with Sketch. 344
    clock Created with Sketch.
    09/04/24
    21:46
    Post #: 73266106
    I am interested to know how they will obtain capital to proceed with trials of all these clinical stage assests. Is SYNBV going to raise capital? Because there is no way Adalta can raise anything substantial at these levels.
    Last edited by asx11: 09/04/24
    1AD Price at posting: 2.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Drill, drill, drill: 3 explorers with news on Friday – Sun Silver, Aurelia & PNX Metals
right-arrow Created with Sketch.
NEWS From the Floor: Gold questions answered...
right-arrow Created with Sketch.
TLX Telix dips as pharma giant abandons US IPO for NASDAQ listing – despite record run
right-arrow Created with Sketch.
NEWS MiningNews Select Conference: Inflation and global shifts pose funding challenges for Aus miners
right-arrow Created with Sketch.
AL8 "What is the focus of AL8 and how is management going to attract shareholders to the registry?"
right-arrow Created with Sketch.
TSO Tesoro reports gold grading 173g/t in Chile, sending share price soaring
right-arrow Created with Sketch.
watchlist Created with Sketch. Add 1AD (ASX) to my watchlist
(20min delay)
Last
2.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.89M
Open High Low Value Volume
2.5¢ 2.5¢ 2.5¢ $850 34K

Buyers (Bids)

No. Vol. Price($)
4 2294371 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.6¢ 687066 3
View Market Depth
Last trade - 10.00am 19/06/2024 (20 minute delay) ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.